Skip to content

Treatment of Venous Thromboembolism and Prevention of Vte Recurrence in Children and Adolescents Aged Less Than 18 Years

The medicines shown here belong to the Blood Thinners category and are used for managing Treatment of Venous Thromboembolism and Prevention of Vte Recurrence in Children and Adolescents Aged Less Than 18 Years. Products containing Rivaroxaban feature in this group.

Xarelto

Rivaroxaban

15mg

Directly inhibits factor Xa to interrupt both intrinsic and extrinsic coagulation pathways, reducing thrombin generation and preventing formation and extension of blood clots.

From$2.98/ tabletView

Review product labelling and speak with a healthcare professional before treatment decisions.